Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

TCM Biotech International Corp. (4169) Income Statement

TCM Biotech International Corp. Income Statement

Last quarter (Q2 2026), TCM Biotech International Corp.'s total revenue was NT$181.09M, a decrease of 46.40% from the same quarter last year. In Q2, TCM Biotech International Corp.'s net income was NT$-8.48M. See TCM Biotech International Corp.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 685.49MNT$ 666.53MNT$ 969.62MNT$ 802.42MNT$ 702.05M
NT$ 296.68MNT$ 327.31MNT$ 480.17MNT$ 448.49MNT$ 358.72M
NT$ 278.02MNT$ 317.30MNT$ 457.84MNT$ 422.70MNT$ 356.59M
Depreciation and AmortizationNT$ 23.53MNT$ 23.87MNT$ 21.89MNT$ 20.00MNT$ 18.05M
NT$ 42.18MNT$ 50.49MNT$ 46.70MNT$ 45.51MNT$ 22.28M
NT$ 18.65MNT$ 10.01MNT$ 22.33MNT$ 25.30MNT$ 2.13M
NT$ 3.64MNT$ 14.32MNT$ -297.00KNT$ -2.18MNT$ 126.00K
NT$ 22.30MNT$ 25.02MNT$ 22.03MNT$ 23.13MNT$ 2.26M
NT$ 19.17MNT$ 21.01MNT$ 18.57MNT$ 18.27MNT$ 1.87M
Per Share Metrics
Basic EPSNT$ 0.32NT$ 0.36NT$ 0.35NT$ 0.37NT$ 0.04
Diluted EPSNT$ 0.32NT$ 0.36NT$ 0.35NT$ 0.37NT$ 0.04
Weighted Average Shares Outstanding59.05M59.05M53.05M49.05M50.74M
Weighted Average Shares Outstanding (Diluted)59.07M59.08M53.05M49.11M50.74M

Currency in TWD

TCM Biotech International Corp. Earnings and Revenue History

0400M800M1.2B0 %2 %4 %6 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin